Shock wave therapy could be new hope for jaw pain sufferers

NCT ID NCT05907239

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether focused shock wave therapy can reduce pain and improve jaw function in people with temporomandibular disorders (TMD) of muscular origin. One hundred adults with moderate to severe jaw pain for at least 3 months will receive either shock wave therapy or a sham treatment. Researchers will measure pain, jaw movement, and quality of life over 5 weeks of treatment and follow up for 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
focused extracorporeal shock wave therapy (device)
What this could lead to
If it works, this could offer a non-drug option for reducing jaw pain and improving jaw movement in people with TMD.
What could go wrong
This is a small, early-stage trial with no phase designation. The treatment may not provide lasting pain relief, and some people may find the shocks uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL SHOCKWAVE THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of São Paulo General Hospital

    RECRUITING

    São Paulo, São Paulo, 05403-010, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.